13.07.2015 Views

INFECTIOUS DISEASES - Blackherbals.com

INFECTIOUS DISEASES - Blackherbals.com

INFECTIOUS DISEASES - Blackherbals.com

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Continued from page 24 – Chik Virusof CHIK fever is supportive. No licensed CHIKVvaccine exists. Therefore, prevention re<strong>com</strong>mendationsfor travelers to tropical Asia and Africa shouldemphasize mosquito repellent and avoidancemeasures. Additional information is available athttp://www.cdc.gov/ncidod/dvbid/chikungunya/chickvfact.htmDuring May 2004-May 2006, approximately 300 000suspected CHIK fever cases were reported on islandsin the Indian Ocean, including approximately 264000 suspected cases on Reunion, a French overseasdepartment (2,3). Other affected areas includedMombasa, Kenya, and the islands of Comoros, Lamu,Madagascar, Mauritius, Mayotte, and the Seychelles.In addition, since early 2006, an estimated 180,000suspected CHIK fever cases have occurred in theIndian states of Andhra Pradesh, Karnataka, andMaharashtra (4). In recent years, extensive CHIKVactivity also has been documented in Southeast Asia(9). In 2006, as of 11 May, approximately 340imported CHIK fever cases were reported in Europe,mainly in France, reflecting the high frequency oftravel between Europe and islands in the IndianOcean (2). To date, no known local mosquito-borneCHIKV transmission has occurred in Europe or othernon-indigenous areas._Aedes aegypti_ is the primary CHIKV vector inAsia, but _Ae. albopictus_ (the Asian tiger mosquito)likely was the primary vector in Reunion (2,3). InAsia, CHIKV epidemics involve a human-mosquitocycle with humans serving as the sole vertebrateamplifying hosts (1). In Africa, sylvatic cyclesinvolving nonhuman primates and forest-dwellingAedes species (e.g., _Ae. furcifer_) also occur. MostCHIKV epidemics occur during the tropical rainyseason and abate during the dry season (1,9). HumanCHIKV infections include a transient, high-titeredviremia (typically detectable during the first 2 days ofillness, ranging up to 6 days after illness onset) that isadequate to infect feeding mosquitoes (1). _Ae.aegypti_ and _Ae. albopictus_ are abundantperidomestic species and aggressive daytime bloodfeedersin all tropical and most subtropical areas ofthe world, and _Ae. albopictus_ now lives in manytemperate areas of the eastern and westernhemispheres, including Europe and the United States.Therefore, some risk exists that CHIKV might beintroduced into previously nonendemic areas bytravelers with viremia, leading to local transmissionof the virus, especially in tropical or subtropical areasof the United States (e.g., the Gulf Coast and Hawaii)or its territories (e.g., Guam, Puerto Rico, and the U.S.Virgin Islands).Early recognition of local transmission followed byprompt, aggressive vector control and other public healthmeasures might prevent long-term establishment of thevirus in new areas. Of the 4 patients described in thisreport, 3 posed no substantial public health risk becausethey probably no longer had viremia upon arrival in theUnited States; although the 4th patient was likely viremicupon arrival in Minnesota in mid-May, transmission to<strong>com</strong>petent local mosquito vectors in that climate wasunlikely.In early illness, the clinical features of CHIK fever can besimilar to those of dengue and malaria, especially inpatients without joint symptoms. In both dengue andCHIK fever, rash usually is generalized. During 1991-2004, 9 confirmed or probable cases of CHIK fever werediagnosed serologically at CDC among travelers to theUnited States (CDC, unpublished data, 2006). Additionalimported but unrecognized cases likely occurred.Clinicians should be aware of possible CHIKV infectionin travelers returning from CHIK-fever--endemic oroutbreak areas, particularly if an acute febrile illness witharthralgias or arthritis occurs. Suspected cases should bereported promptly to local and state public health officialsand to CDC. Mosquito exposure should be strictlyavoided (e.g., by staying within a screened environmentand using barrier clothing and repellents) during the firstweek of illness to prevent infection of local mosquitoes.In the United States, diagnostic tests for CHIKV infectionare not available <strong>com</strong>mercially but are available at CDCby special arrangement through state health departments.Laboratory diagnosis depends on antibody-capture IgMELISA and plaque-reduction neutralization tests ofserum. Comparative serologic tests for closely relatedalphaviruses (e.g., o'nyong-nyong and Sindbis viruses)should be conducted as geographically appropriate, andtests for dengue usually are indicated. Virus isolationattempts and PCR assays are performed selectively.Serologic tests should be performed on both acute- andconvalescent-phase serum specimens collected at least 2weeks apart, but clinicians should not delay submissionof acute-phase samples pending collection ofconvalescent-phase samples. To arrange submission ofspecimens to CDC for diagnostic testing, cliniciansshould consult their state public health laboratory andCDC's Arboviral Diseases Branch (telephone, 970-221-6400). Specimen shipping and handling instructions areavailable athttp://www.cdc.gov/ncidod/dvbid/misc/specimensubmission.htmContinued on page 26-25- Traditional African Clinic December 2006

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!